Sector portfolio · Government fund · United States
Connecticut Innovations' Biotech portfolio
Connecticut Innovations has backed 33 Biotech startups in rounds we track, $1.0B between them, shown by the stage each has reached. The best-funded is Biohaven Pharmaceutical.
33startups backed
4stages
$1.0Braised between them
Stage not reportedbiggest stage
Connecticut Innovations's whole portfolioConnecticut Innovations's profile
Funding by segment
- Stage not reported$477M15
- Series A$180M8
- Series B$354M7
- Pre-seed and seed$19M3
Where they are based
- United States31$1.0B
United StatesFounded
8Earlier
212
313
214
115
216
217
518
19
320
121
22
23
24
25
26
4 without a founding year on record.
Total raised
- Under $1M3
- $1M to $10M14
- $10M to $50M11
- $50M to $250M4
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
29 of 33 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States31
Startups by country, 1 country in all.
Segment by segment
Stage not reported
15 startups · $477M raised
Biohaven PharmaceuticalBiohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.United States$280M
ArvinasArvinas is a clinical-stage biotechnology company leading the way in targeted protein degradation therapeutics.United States$111M
Inbox HealthInbox Health is a healthcare technology company based in New Haven, Connecticut, founded in 2014.United States$29M
Thetis PharmaceuticalsThetis Pharmaceuticals is a biopharmaceutical company.United States$16M
Artizan BiosciencesArtizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.United States$14M
BEKHealthBEKhealth is an AI-powered clinical intelligence company that enhances electronic health record (EHR) data for clinical research.United States$9.0M
OncoSynergyOncoSynergy is a clinical-stage biotechnology startup focused on immuno-oncology, founded in 2011 and headquartered in Stamford, Connecticut.United States$6.6M
ReNetX BioReNetX Bio is a clinical-stage biotechnology company based in New Haven, Connecticut.United States$2.8M
Series A
8 startups · $180M raised
AzitraAzitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.United States$49M
RallybioRallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.United States$44M
Alphina TherapeuticsAlphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients.United States$40M
OOVAOova is a women's health and fertility technology company that specializes in at-home hormone monitoring.United States$11M
AnceraAncera is a technology company that specializes in software solutions for food production, focusing on enhancing security, efficieUnited States$10M
Diameter HealthDiameter Health is a software company that offers processing, predictive analytics, patient risk assessment, and data use.United States$9.8M- TBTangen BiosciencesTangen Biosciences is a biotechnology company that offers molecular diagnostic technology services.United States$9.0M
Affomix CorporationAffomix develops technology for the automated, high-throughput selection of human monoclonal antibodies.United States$7.0M
Series B
7 startups · $354M raised
- HTHalda TherapeuticsHalda Therapeutics is a research-stage drug discovery company.United States$126M
NormunityNormunity is a biotechnology company founded in 2020, focused on developing innovative precision immuno-oncology therapies.United States$75M
Allyx TherapeuticsAllyx Therapeutics is a clinical-stage biotechnology company based in New Haven, Connecticut, founded in 2019.United States$61M
Cybrexa TherapeuticsCybrexa Therapeutics is a clinical-stage oncology biotechnology company based in New Haven, Connecticut, founded in 2017.United States$44M
Simcha TherapeuticsSimcha Therapeutics is a clinical-stage immunobiology company based in New Haven, Connecticut.United States$40M
Bioarray GeneticsBioarray Genetics is a molecular diagnostics and genetic testing company based in Farmington, Connecticut.United States$4.0M
Precipio DiagnosticsPrecipio Diagnostics is a cancer diagnostics reference laboratory delivering advanced diagnostics, advice and personalized medicine.United States$3.4M
Pre-seed and seed
3 startups · $19M raised
Revalia BioRevalia Bio develops curative drugs for chronic organ-centered disease.United States$15M- MBModifi BioModifi Biosciences is a leader in direct DNA modification and the development of novel cancer therapeutics.United States$4.3M
Pattern GenomicsPattern Genomics develops Daydreamer, a software platform that enables simultaneous pattern analysis of DNA sequences and molecular assay.United States$150K
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Connecticut Innovations as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosSector portfolioConnecticut Innovations' Healthtech portfolio11 startups · $32MPortfolio mapConnecticut Innovations portfolio map93 startups · $2.5BCo-investorsWho invests with Connecticut Innovations37 co-investorsSector portfolioNational Science Foundation's Biotech portfolio250 startups · $2.0BSector portfolioNational Science Foundation's Healthtech portfolio149 startups · $516MSector portfolioNational Institutes of Health's Biotech portfolio145 startups · $2.5B
Raising from investors like Connecticut Innovations?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.